Q32 Bio (QTTB) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
12 Jun, 2026Opening remarks and agenda
The meeting was called to order by the CEO, with formal business limited to items described in the notice and proxy statement.
Attendance included the board, executive team, audit firm, and legal counsel.
Stockholders were informed of voting and question procedures for the virtual meeting.
Board and executive committee updates
Three nominees for Class II directors were presented for election to serve three-year terms.
No stockholder nominations for directors were received in advance.
Shareholder proposals
Proposals included election of directors, ratification of the audit firm, and a non-binding advisory vote on executive compensation.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Q32 Bio
- Registering up to $300M in securities to advance lead autoimmune therapy and fund operations.QTTB
Registration filing25 Jun 2026 - Q1 2026 net loss narrowed to $7.6M; cash runway into 2028 after equity raises and asset sale.QTTB
Q1 20265 May 2026 - Lead asset bempikibart delivers durable AA responses and strong safety, with pivotal data due mid-2026.QTTB
Company presentation5 May 2026 - Virtual annual meeting to vote on directors, auditor, and executive pay, with strong governance.QTTB
Proxy filing30 Apr 2026 - Election of directors, auditor ratification, and say-on-pay up for shareholder vote.QTTB
Proxy filing30 Apr 2026 - Lead asset bempikibart targets unmet needs in alopecia areata, with pivotal data due mid-year.QTTB
25th Annual Needham Virtual Healthcare Conference15 Apr 2026 - Bempikibart delivers durable, safe hair regrowth in AA, with pivotal data expected mid-2026.QTTB
Company presentation10 Mar 2026 - Q4 2025 net income surged on asset sales, with cash runway secured into late 2027.QTTB
Q4 202510 Mar 2026 - Bempikibart shows promise as a safer, durable biologic for alopecia areata, with key data due midyear.QTTB
Oppenheimer 36th Annual Healthcare Life Sciences Conference25 Feb 2026